Your clinician can monitor your progress and make adjustments to the tapering schedule as needed
So is this an affordable middle ground
It must not be injected, ingested, applied to humans, or introduced into any clinical setting
[1] When to Seek Medical Advice Seek immediate medical attention (call 999 or attend A&E) if you experience: Signs of severe allergic reaction (anaphylaxis) : difficulty breathing, swelling of face/lips/tongue/throat, severe rash or hives, rapid pulse, dizziness or fainting Contact NHS 111 or seek urgent GP advice if you develop: Severe, persistent abdominal pain (possibly radiating to the back), with or without vomiting, which may indicate pancreatitis [1] Severe upper right abdominal pain, fever, or yellowing of skin or eyes (jaundice), which may suggest gallbladder problems Severe or persistent gastrointestinal symptoms preventing adequate fluid or food intake Signs of dehydration (dark urine, dizziness, reduced urination, extreme thirst) Contact your GP if you notice: Persistent injection site reactions lasting more than one week Signs of infection at injection sites (increasing warmth, spreading redness, pus, fever) Recurrent hypoglycaemia if taking diabetes medications Unexplained visual changes or severe headaches A lump or swelling in the neck, persistent hoarseness, difficulty swallowing, or shortness of breath Symptoms of depression or suicidal thoughts (rare but reported) Routine follow-up with your prescribing clinician is essential for monitoring treatment response, managing side effects, and adjusting doses appropriately
For a researcher on 8mg weekly, this means injecting 4mg every 3.5 days
The mechanism of action is attributed to the GIP/GLP-1 receptor co-agonism being enhanced by glucagon receptor activation and augmentation of energy intake, substrate utilisation and energy expenditure [60]
